Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Neoplasms × Fentanyl × Clear all

Phase

Phase 3 8 Phase 2 6 Phase NA 1 Phase 4 1 Phase 2/3 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pain 1 Neoplasms 1 Chronic Pain 1 Breakthrough Pain 1

Interventions

pembrolizumab 37 Nivolumab 24 Gemcitabine 24 Paclitaxel 16 Carboplatin 14 Cyclophosphamide 12 Cisplatin 12 Ipilimumab 10 Capecitabine 10 Irinotecan 8 Docetaxel 8 Dexamethasone 8 Bevacizumab 8 130-nm albumin-bound paclitaxel 8 Rituximab 7 Albumin-Bound Paclitaxel 7 Temozolomide 6 Sorafenib 6 Pemetrexed 6 Cetuximab 6 Azacitidine 6 Ascorbic Acid 6 spartalizumab 5 lenvatinib 5 fludarabine 5 cemiplimab 5 Radiotherapy 5 ibrutinib 4 avelumab 4 atezolizumab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01248611 2014-05-12

NFCP1-2010

St. Olavs Hospital

Phase 1/2 Completed

Neoplasms, Pain, Chronic Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡